Displaying all 7 publications

Abstract:
Sort:
  1. Azarisman SM, Magdi YA, Noorfaizan S, Oteh M
    N Engl J Med, 2007 Nov 1;357(18):1873-4.
    PMID: 17978302 DOI: 10.1056/NEJMc070990
    Matched MeSH terms: Cyclobutanes/adverse effects*
  2. Saifuddin, T.M., Rahim, N., Mansor, N.Z.
    MyJurnal
    Sibutramine is a prohibited weight-reducing agent used in many weight-loss
    products, which has been banned in many countries since 2010 including
    Malaysia due to it toxicities and mortality effect. The widespread use of these
    sibutramine-containing products has raised concerns regarding their side
    effects, which include psychological symptoms. In this case report, we
    highlight a case of psychosis induced by the use of this product. We present a
    case of 36-year-old Burmese lady who has three admissions to psychiatry
    ward with psychotic presentation after on-going consumption of weight-loss
    product containing sibutramine.
    Matched MeSH terms: Cyclobutanes
  3. Nur Ain Izzati M, Wan Hasmida W
    Microfungi isolated from Malay traditional vegetables such as Centella asiatica, Cosmos caudatus, Oenanthe javanica, Persicaria odorata and Psophocarpus tetragonolobus are well diverse. A total of 40 isolates of the fungi were identified and classified into four genera such as Aspergillus, Fusarium, Penicillium and Trichoderma. Five species of Fusarium were morphologically identified as F. oxysporum, F. semitectum, F. proliferatum, F. solani and F. konzum. Three species of Aspergillus were identified as A. niger, A. fumigatus and A. flavus. The highest number of microfungi was isolated from Cosmos caudatus (12 isolates), followed by Persicaria odorata (9 isolates), Oenanthe javanica (8 isolates), Centella asiatica (6 isolates) and Psophocarpus tetragonolobus (5 isolates). Four isolates of Fusarium species were able to produce moniliformin (MON) and five isolates were able to produce fumonisin B1 (FB1). This is the first report on diversity of microfungi associated with some Malay traditional vegetables.
    Matched MeSH terms: Cyclobutanes
  4. Nor Azliza I, Hafizi R, Nurhazrati M, Salleh B
    Sains Malaysiana, 2014;43:89-94.
    The Fusarium species are notoriously known for causing various plants and animal diseases and producing a number of harmful mycotoxins. The mycotoxins production by species recovered from non-agricultural hosts such as wild grasses have hitherto never been given attention. We examined 30 strains representing 12 Fusarium species i.e. F. oxysporum, F. solani, F. semitectum, F. nelsonii, F. compactum, F. equiseti, F. chlamydosporum, F. proliferatum, F. subglutinans, F. sacchari, F. lateritium and F. incarnatum-equiseti species complex isolated from wild grasses in Peninsular Malaysia for the production of four major mycotoxins i.e. moniliformin (MON), fumonisin BI (FB1), zearalenone (ZEN) and beauvericin (BEA) using TLC and HPLC techniques. BEA was the highest frequency of mycotoxin detected, followed by MON, ZEN and FB1. This study also presented the first report of BEA production by F. solani, F. compactum and F. chlamydosporum. All mycotoxins were not produced by F. nelsonii and F. lateritium. All Fusarium species were isolated from asymptomatic grasses, hence they are likely to exist as endophytes or latent pathogens.
    Matched MeSH terms: Cyclobutanes
  5. Al-Khdhairawi AAQ, Krishnan P, Mai CW, Chung FF, Leong CO, Yong KT, et al.
    J Nat Prod, 2017 10 27;80(10):2734-2740.
    PMID: 28926237 DOI: 10.1021/acs.jnatprod.7b00500
    Tengerensine (1), isolated as a racemate and constituted from a pair of bis-benzopyrroloisoquinoline enantiomers, and tengechlorenine (2), purified as a scalemic mixture and constituted from a pair of chlorinated phenanthroindolizidine enantiomers, were isolated from the leaves of Ficus fistulosa var. tengerensis, along with three other known alkaloids. The structures of 1 and 2 were determined by spectroscopic data interpretation and X-ray diffraction analysis. The enantiomers of 1 were separated by chiral-phase HPLC, and the absolute configurations of (+)-1 and (-)-1 were established via experimental and calculated ECD data. Compound 1 is notable in being a rare unsymmetrical cyclobutane adduct and is the first example of a dimeric benzopyrroloisoquinoline alkaloid, while compound 2 represents the first naturally occurring halogenated phenanthroindolizidine alkaloid. Compound (+)-1 displayed a selective in vitro cytotoxic effect against MDA-MB-468 cells (IC50 7.4 μM), while compound 2 showed pronounced in vitro cytotoxic activity against all three breast cancer cell lines tested (MDA-MB-468, MDA-MB-231, and MCF7; IC50 values of 0.038-0.91 μM).
    Matched MeSH terms: Cyclobutanes/isolation & purification*; Cyclobutanes/pharmacology*; Cyclobutanes/chemistry
  6. Al-Tahami BAM, Al-Safi Ismail AA, Sanip Z, Yusoff Z, Shihabudin TMT, Singh TSP, et al.
    J Nippon Med Sch, 2017;84(3):125-132.
    PMID: 28724846 DOI: 10.1272/jnms.84.125
    INTRODUCTION: Obesity is associated with numerous health problems, particularly metabolic and cardiovascular complications. This study aimed to assess the effects that, nine months of pharmacological intervention with orlistat or sibutramine, on obese Malaysians' body weight and compositions, metabolic profiles and inflammatory marker.

    METHODS: Seventy-six obese subjects were randomly placed into two groups. The first group received three daily 120 mg dosages of orlistat for nine months (n=39), and the second group received a once daily 10 or 15 mg dosage of sibutramine for nine months (n=37). Baseline measurements for weight, body mass index (BMI), waist circumference (WC), body fat percentage (BF), visceral fat (VF), adiponectin, fasting plasma glucose (FPG), fasting insulin, pancreatic B cell secretory capacity (HOMA%B), insulin sensitivity (HOMA%S), insulin resistance (HOMA-IR) and serum high sensitivity C-reactive protein (hs-CRP) were performed and repeated during the sixth and ninth months of treatment.

    RESULTS: Twenty-four subjects completed the trial in both groups. For both groups, weight, BMI, WC, BF, VF, HOMA-IR and hs-CRP were significantly lower at the end of the nine month intervention. However, there were no significant differences between the two groups for these parameters with nine months treatment. There was a significant decrease in FPG in orlistat group; while fasting insulin and HOMA%B reduced in sibutramine group. For both groups, there were also significant increases in adiponectin levels and HOMA%S at the end of the nine month intervention.

    CONCLUSION: Nine months of treatment with orlistat and sibutramine not only reduced weight but also significantly improved BMI, WC, BF, VF, FPG, adiponectin, fasting insulin, HOMA%B, HOMA%S, HOMA-IR and hs-CRP. These improvements could prove useful in the reduction of metabolic and cardiovascular risks in obese subjects.

    Matched MeSH terms: Cyclobutanes/administration & dosage*; Cyclobutanes/pharmacology
  7. Al-Tahami BA, Ismail AA, Bee YT, Awang SA, Salha Wan Abdul Rani WR, Sanip Z, et al.
    Clin. Hemorheol. Microcirc., 2015;59(4):323-34.
    PMID: 24002121 DOI: 10.3233/CH-131765
    INTRODUCTION: Obesity is associated with impaired microvascular endothelial function. We aimed to determine the effects of orlistat and sibutramine treatment on microvascular endothelial function, anthropometric and lipid profile, blood pressure (BP), and heart rate (HR).
    METHODS: 76 subjects were recruited and randomized to receive orlistat 120 mg three times daily or sibutramine 10 mg daily for 9 months. Baseline weight, BMI, BP, HR and lipid profile were taken. Microvascular endothelial function was assessed using laser Doppler fluximetry and iontophoresis process. Maximum change (max), percent change (% change) and peak flux (peak) in perfusion to acetylcholine (ACh) and sodium nitroprusside (SNP) iontophoresis were used to quantify endothelium dependent and independent vasodilatations.
    RESULTS: 24 subjects in both groups completed the trial. After treatment, weight and BMI were decreased for both groups. AChmax, ACh % change and ACh peak were increased in orlistat-treated group but no difference was observed for sibutramine-treated group. BP and total cholesterol (TC) were reduced for orlistat-treated group. HR was reduced for orlistat-treated group but was increased in sibutramine-treated group.
    CONCLUSION: 9 months treatment with orlistat significantly improved microvascular endothelial function. This was associated with reductions in weight, BMI, BP, HR, TC and low density lipoprotein cholesterol. No effect was seen in microvascular endothelial function with sibutramine.
    KEYWORDS: Microvascular endothelial function; obesity; orlistat; sibutramine
    Matched MeSH terms: Cyclobutanes/pharmacology*
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links